期刊
JOURNAL OF MEDICINAL CHEMISTRY
卷 57, 期 20, 页码 8664-8670出版社
AMER CHEMICAL SOC
DOI: 10.1021/jm5011397
关键词
-
资金
- The Wellcome Trust [087792]
- BBSRC [BB/D02014X/1] Funding Source: UKRI
- EPSRC [EP/K039946/1] Funding Source: UKRI
- MRC [G0900278] Funding Source: UKRI
- Biotechnology and Biological Sciences Research Council [BB/D02014X/1] Funding Source: researchfish
- Engineering and Physical Sciences Research Council [1098649, EP/K039946/1] Funding Source: researchfish
- Medical Research Council [G0900278] Funding Source: researchfish
Inhibitors of Leishmania N-myristoyltransferase (NMT), a potential target for the treatment of leishmaniasis, obtained from a high-throughput screen, were resynthesized to validate activity. Crystal structures bound to Leishmania major NMT were obtained, and the active diastereoisomer of one of the inhibitors was identified. On the basis of structural insights, enzyme inhibition was increased 40-fold through hybridization of two distinct binding modes, resulting in novel, highly potent Leishmania donovani NMT inhibitors with good selectivity over the human enzyme.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据